ANISH PATEL: Open Payments
NPI 1861901712 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 20 payments from 9 companies in 2025. Trend: 2023 $1,749 · 2024 $1,028 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $100 |
| E.R. Squibb & Sons, L.L.C. | 4 | $89 |
| Vanda Pharmaceuticals Inc. | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Indivior Inc. | 1 | $40 |
| Lundbeck LLC | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Corium, LLC | 3 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: VRAYLAR, COBENFY, AUSTEDO XR, SUBLOCADE, FANAPT, REXULTI, Auvelity, Azstarys.
Industry payments across AZ — which companies pay providers there.
